Michelle Salazar, MD, MHS
Hospital Resident
Research & Publications
Biography
News
Coauthors
Selected Publications
- Change in facility-level share of Medicaid patients with cancer following implementation of the affordable care act.Buck M, Demkowicz P, Nie J, Marks V, Salazar M, Kenney P, Boffa D, Leapman M. Change in facility-level share of Medicaid patients with cancer following implementation of the affordable care act. Journal Of Clinical Oncology 2021, 39: e18543-e18543. DOI: 10.1200/jco.2021.39.15_suppl.e18543.
- Survival After Cancer Treatment at Top-Ranked US Cancer Hospitals vs Affiliates of Top-Ranked Cancer HospitalsBoffa DJ, Mallin K, Herrin J, Resio B, Salazar MC, Palis B, Facktor M, McCabe R, Nelson H, Shulman LN. Survival After Cancer Treatment at Top-Ranked US Cancer Hospitals vs Affiliates of Top-Ranked Cancer Hospitals. JAMA Network Open 2020, 3: e203942. PMID: 32453382, PMCID: PMC7251445, DOI: 10.1001/jamanetworkopen.2020.3942.
- Quality Versus QuantityChiu AS, Arnold BN, Hoag JR, Herrin J, Kim CH, Salazar MC, Monsalve AF, Jean RA, Blasberg JD, Detterbeck FC, Gross CP, Boffa DJ. Quality Versus Quantity. Annals Of Surgery 2019, Publish Ahead of Print: &na;. PMID: 29697446, DOI: 10.1097/sla.0000000000002762.
- Gallbladder Agenesis: A Case Report.Salazar MC, Brownson KE, Nadzam GS, Duffy A, Roberts KE. Gallbladder Agenesis: A Case Report. The Yale Journal Of Biology And Medicine 2018, 91: 237-241. PMID: 30258310, PMCID: PMC6153629.
- Timing and Risk Factors Associated With Venous Thromboembolism After Lung Cancer ResectionThomas DC, Arnold BN, Hoag JR, Salazar MC, Detterbeck FC, Boffa DJ, Kim AW, Blasberg JD. Timing and Risk Factors Associated With Venous Thromboembolism After Lung Cancer Resection. The Annals Of Thoracic Surgery 2018, 105: 1469-1475. PMID: 29501644, DOI: 10.1016/j.athoracsur.2018.01.072.
- Spontaneous regionalization of esophageal cancer surgery: an analysis of the National Cancer DatabaseArnold BN, Chiu AS, Hoag JR, Kim CH, Salazar MC, Blasberg JD, Boffa DJ. Spontaneous regionalization of esophageal cancer surgery: an analysis of the National Cancer Database. Journal Of Thoracic Disease 2018, 10: 1721-1731. PMID: 29707326, PMCID: PMC5906219, DOI: 10.21037/jtd.2018.02.12.
- Fate of Pneumonectomy Patients Variably Captured by Non-Small Cell Lung Cancer Staging SystemDhanasopon AP, Salazar MC, Hoag JR, Rosen JE, Kim AW, Detterbeck FC, Blasberg JD, Boffa DJ. Fate of Pneumonectomy Patients Variably Captured by Non-Small Cell Lung Cancer Staging System. The Annals Of Thoracic Surgery 2017, 104: 1829-1836. PMID: 29074151, DOI: 10.1016/j.athoracsur.2017.06.073.
- The Significance of Upfront Knowledge of N2 Disease in Non-small Cell Lung CancerThomas DC, Arnold BN, Rosen JE, Salazar MC, Detterbeck FC, Blasberg JD, Boffa DJ, Kim AW. The Significance of Upfront Knowledge of N2 Disease in Non-small Cell Lung Cancer. World Journal Of Surgery 2017, 42: 161-171. PMID: 28799084, DOI: 10.1007/s00268-017-4165-6.
- Length of Stay From the Hospital PerspectiveRosen JE, Salazar MC, Dharmarajan K, Kim AW, Detterbeck FC, Boffa DJ. Length of Stay From the Hospital Perspective. Annals Of Surgery 2017, 266: 383-388. PMID: 27564681, DOI: 10.1097/sla.0000000000001971.
- Effectiveness of local therapy for stage I non–small-cell lung cancer in nonagenariansArnold BN, Thomas DC, Rosen JE, Salazar MC, Detterbeck FC, Blasberg JD, Boffa DJ, Kim AW. Effectiveness of local therapy for stage I non–small-cell lung cancer in nonagenarians. Surgery 2017, 162: 640-651. PMID: 28697883, DOI: 10.1016/j.surg.2017.04.025.
- Cellular Expression of PD-L1 in the Peripheral Blood of Lung Cancer Patients is Associated with Worse SurvivalBoffa DJ, Graf RP, Salazar MC, Hoag J, Lu D, Krupa R, Louw J, Dugan L, Wang Y, Landers M, Suraneni M, Greene SB, Magaña M, Makani S, Bazhenova L, Dittamore RV, Nieva J. Cellular Expression of PD-L1 in the Peripheral Blood of Lung Cancer Patients is Associated with Worse Survival. Cancer Epidemiology Biomarkers & Prevention 2017, 26: 1139-1145. PMID: 28446544, PMCID: PMC5500408, DOI: 10.1158/1055-9965.epi-17-0120.
- The impact of tumor size on survival in T3 non-small cell lung-cancer with direct extension.Kim C, Salazar M, Hoag J, Rosen J, Arnold B, Boffa D, Blasberg J. The impact of tumor size on survival in T3 non-small cell lung-cancer with direct extension. Journal Of Clinical Oncology 2017, 35: e20033-e20033. DOI: 10.1200/jco.2017.35.15_suppl.e20033.
- Validating the Thoracic Revised Cardiac Risk Index Following Lung ResectionThomas DC, Blasberg JD, Arnold BN, Rosen JE, Salazar MC, Detterbeck FC, Boffa DJ, Kim AW. Validating the Thoracic Revised Cardiac Risk Index Following Lung Resection. The Annals Of Thoracic Surgery 2017, 104: 389-394. PMID: 28499655, DOI: 10.1016/j.athoracsur.2017.02.006.
- Association of Delayed Adjuvant Chemotherapy With Survival After Lung Cancer SurgerySalazar MC, Rosen JE, Wang Z, Arnold BN, Thomas DC, Herbst RS, Kim AW, Detterbeck FC, Blasberg JD, Boffa DJ. Association of Delayed Adjuvant Chemotherapy With Survival After Lung Cancer Surgery. JAMA Oncology 2017, 3: 610-619. PMID: 28056112, PMCID: PMC5824207, DOI: 10.1001/jamaoncol.2016.5829.
- Defining outcomes of patients with clinical stage I small cell lung cancer upstaged at surgeryThomas DC, Arnold BN, Rosen JE, Salazar MC, Blasberg JD, Detterbeck FC, Boffa DJ, Kim AW. Defining outcomes of patients with clinical stage I small cell lung cancer upstaged at surgery. Lung Cancer 2016, 103: 75-81. PMID: 28024700, DOI: 10.1016/j.lungcan.2016.11.016.
- 75P PD-L1 expression on circulating CD45(-) cells is an independent prognostic factor for overall survival (OS) in patients (Pts) across all stages of treatment-naïve lung cancer in a prospective, multicenter studyGraf R, Lu D, Krupa R, Louw J, Dugan L, Jendrisak A, Orr S, Bethel K, Wang Y, Suraneni M, Landers M, Boffa D, Nieva J, Bazhenova L, Salazar M, Makani S, Magana M, Dittamore R. 75P PD-L1 expression on circulating CD45(-) cells is an independent prognostic factor for overall survival (OS) in patients (Pts) across all stages of treatment-naïve lung cancer in a prospective, multicenter study. Annals Of Oncology 2016, 27: vi22. DOI: 10.1093/annonc/mdw363.23.
- Outcomes of a Highly Selective Surgical Approach to Oligometastatic Lung CancerJohnson KK, Rosen JE, Salazar MC, Boffa DJ. Outcomes of a Highly Selective Surgical Approach to Oligometastatic Lung Cancer. The Annals Of Thoracic Surgery 2016, 102: 1166-1171. PMID: 27344278, DOI: 10.1016/j.athoracsur.2016.04.086.
- Programmed cell death-1 ligand (PD-L1) expression on circulating CD45(-) cells is an independent prognostic factor for overall survival in patients (Pts) with lung cancer in a prospective, multicenter cohort.Boffa D, Nieva J, Bazhenova L, Krupa R, Lu D, Graf R, Louw J, Dugan L, Jendrisak A, Salazar M, Makani S, Magana M, Orr S, Bethel K, Wang Y, Marrinucci D, Dittamore R. Programmed cell death-1 ligand (PD-L1) expression on circulating CD45(-) cells is an independent prognostic factor for overall survival in patients (Pts) with lung cancer in a prospective, multicenter cohort. Journal Of Clinical Oncology 2016, 34: 8524-8524. DOI: 10.1200/jco.2016.34.15_suppl.8524.
- Lung Cancer in the Very Young: Treatment and Survival in the National Cancer Data BaseArnold BN, Thomas DC, Rosen JE, Salazar MC, Blasberg JD, Boffa DJ, Detterbeck FC, Kim AW. Lung Cancer in the Very Young: Treatment and Survival in the National Cancer Data Base. Journal Of Thoracic Oncology 2016, 11: 1121-1131. PMID: 27103511, DOI: 10.1016/j.jtho.2016.03.023.
- Lobectomy versus stereotactic body radiotherapy in healthy patients with stage I lung cancerRosen JE, Salazar MC, Wang Z, Yu JB, Decker RH, Kim AW, Detterbeck FC, Boffa DJ. Lobectomy versus stereotactic body radiotherapy in healthy patients with stage I lung cancer. Journal Of Thoracic And Cardiovascular Surgery 2016, 152: 44-54.e9. PMID: 27131846, DOI: 10.1016/j.jtcvs.2016.03.060.
- Adjuvant Chemotherapy for T3 Non–Small Cell Lung Cancer with Additional Tumor Nodules in the Same LobeSalazar MC, Rosen JE, Arnold BN, Thomas DC, Kim AW, Detterbeck FC, Blasberg JD, Boffa DJ. Adjuvant Chemotherapy for T3 Non–Small Cell Lung Cancer with Additional Tumor Nodules in the Same Lobe. Journal Of Thoracic Oncology 2016, 11: 1090-1100. PMID: 27013407, DOI: 10.1016/j.jtho.2016.03.009.